Navigation Links
Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)
Date:6/10/2009

ion is anticipated to jump to $85 billion in the next two decades. As a result, Medicare costs are anticipated to soar 500%, from $5 billion to $30 billion. As the stakes to treat HCV are high, the competition for new drugs is intense with more than sixty treatment candidates reported to be in development. As we target the use of our Hemopurifier(R) as a drug enhancement device in HCV care, we are positioned to improve treatment outcomes as an adjunct to both SOC therapy and new drug candidates that evolve to challenge SOC therapy in the marketplace.

Significant challenges exist for drugs seeking to supplant SOC therapy, as new candidates must demonstrate substantially greater patient benefit in order for the medical community to consider discontinuing administration of the SOC treatment regimen. As an example, Albuferon, an HCV treatment candidate from Human Genome Sciences (HGSI), recently demonstrated phase III treatment outcomes comparable to SOC therapy with half the number of required injections. As a result, the value of HGSI shares was reduced by 57% the day the study data was released. I can't help but wonder how Albuferon might have performed in combination with our Hemopurifier(R)? Regardless, a drug candidate wishing to supplant SOC therapy in the market will need to Bob Beamon (surpassed world long jump record by almost two feet at the 1968 Olympics) beyond the capabilities of SOC therapy.

For this reason, the primary strategy for most HCV drug candidates is to incrementally improve treatment outcomes as an adjunct to SOC therapy. The challenge facing these candidates is the effect of stacking new drug toxicity on top of established SOC toxicity, which is known to trigger fatigue, bone marrow suppression, anemia and neuropsychiatric effects. Many patients fail SOC therapy because they are unable to endure the toxicity of the 24-48 week regimen on its own. Based on clinical data, Telaprevir, a 3x-day o
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online
2. Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs
3. Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus
4. Aethlon Medical Discloses New HIV/AIDS Treatment Data
5. MSU engineering team designs innovative medical device
6. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
7. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
8. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
9. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
10. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
11. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, 2014 (HealthDay ... -- as mandated under the Affordable Care Act -- could ... deny insurance coverage for any medical practice that violates their ... experts counter that such predictions are unlikely to come true. ... Stores Inc. and Conestoga Wood Specialties Corp. did not have ...
(Date:7/28/2014)... 28, 2014 This is a ... Chinese Tadalafil industry. The report firstly reviews the ... and manufacturing technology. The report then explores global ... product specification, capacity, Production value, and market share ... global and China’s total market of Tadalafil by ...
(Date:7/28/2014)... Carolina (PRWEB) July 28, 2014 The ... their first bite of food best, with each subsequent ... the researchers found, can actually serve to sabotage the ... in foods they enjoy, not realizing the effect," Baba ... is the argument for moderation, if we needed one. ...
(Date:7/28/2014)... July 28, 2014 H2T Elite Dryland Training ... Located at 573 Alness Street in Toronto, H2T ... of Steeles. H2T is a state of the art facility ... seniors. There are many gyms out there for people 18 ... seniors alone. H2T will be home to many elite athletes ...
(Date:7/28/2014)... Sussex, Wisconsin (PRWEB) July 28, 2014 ... to help First Lady Michelle Obama and Partnership for ... new organizations as they join the group's DrinkUP ... drink more water, more often. , The seven ... Haws Corporation™, Nalgene® Outdoor Products, S’well Bottle, Santa Clara ...
Breaking Medicine News(10 mins):Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 2Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 3Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 4Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 5Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 4Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3Health News:FS Local Community Member H2T Elite Dryland Training Is Set to Open Its Doors 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 3
... EAST RUTHERFORD, N.J., June 4 Cambrex Corporation (NYSE: ... from the New York Stock Exchange ("NYSE") informing the Company ... listing standards. As announced by the Company on April ... continued listing standards because its average market capitalization over a ...
... 4 NxStage Medical, Inc. (Nasdaq: NXTM ), ... Jeffrey H. Burbank, Chief Executive Officer, will be presenting at ... 2009 at The Four Seasons Hotel in Chicago, IL. ... June 9th at 4:30 p.m. (CST). To listen to ...
... potentially deadly conditions , THURSDAY, June 4 (HealthDay News) ... and forms a scab after a cut? Researchers have ... , "The human body has an incredible ability to ... P. Wong, a principal investigator at the Rowland Institute ...
... Latino Pennsylvanians , , HARRISBURG, Pa., June 4 ... of Estoydecidido.com , a resource tool to help ... Estoydecidido.com -- which translates to "I am determined" ... DeterminedToQuit.com site. , , "Latinos have become ...
... Laboratories, Inc., a leading research-based contract manufacturer of intermediates, ... pleased to announce the issuance by the Tianjin branch ... a manufacturing certificate for drug products to our Tianjin ... dosage forms including tablets, capsules, and pellets. , ...
... , , CLEVELAND, June 4 In ... of six selected to the International Factoring Association Advisory Board. ... Cohen will be asked to provide guidance and feedback to ... board members, Mr. Cohen will also be responsible for communicating ...
Cached Medicine News:Health News:NxStage to Present at the William Blair Growth Stock Conference 2Health News:Researchers Detect Blood-Clotting Mechanism 2Health News:Pennsylvania Department of Health Launches Spanish-Language Smoking Cessation Resource Web Site 2Health News:Asymchem Announces sFDA Certification for Drug Product Manufacturing 2Health News:President of PRN Funding Appointed to Factoring Association Advisory Board 2
(Date:7/28/2014)... England , July 28, 2014 /PRNewswire/ ... dass Albion Ventures 2,5 Millionen £ investiert ... in der Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche ... Ventures.      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ... 18 Monaten hat OmPrompt sein beschleunigtes Wachstum ...
(Date:7/28/2014)... 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... second quarter 2014 financial results for the period ended June ... PDL,s management will host a conference call and webcast that ... results.  A slide presentation relating to the call will be ... Conference Call Details To access the live conference ...
(Date:7/28/2014)... , Germany and ... , Collaboration aims to create and ... to guide the use of IRESSA  for non-small cell ... build on QIAGEN,s FDA-approved  therascreen   EGFR test and is ... of automated instruments  Project enabled by AstraZeneca ...
Breaking Medicine Technology:OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
... TCS Symphony orchestrates images and patient ... and information sources in one central ... workflow and improves cost-effectiveness so that ... they do best, helping people., ,Many ...
... Bright quartz halogen illumination with ... filter for whiter light Worldwide ... controlled fan keeps unit coo. ... change Optional tray will clamp ...
... Lite positions directly over one,eye permitting ... lens an exclusive feature ,resulting ... optic light that penetrates,deep into a ... swivel mount enables the,surgeon to rotate ...
Mounted on a remarkably lightweight and,flexible cotton headband with crown strap,the Sport is fully adjustable....
Medicine Products: